Published in Radiographics on September 16, 2009
The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol (2010) 2.05
Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol (2010) 1.25
Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline. FASEB J (2010) 1.18
Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects. J Magn Reson Imaging (2013) 0.94
Dietary choline requirements of women: effects of estrogen and genetic variation. Am J Clin Nutr (2010) 0.92
Imaging of non alcoholic fatty liver disease: A road less travelled. Indian J Endocrinol Metab (2013) 0.88
Fast lipid and water levels by extraction with spatial smoothing (FLAWLESS): three-dimensional volume fat/water separation at 7 Tesla. J Magn Reson Imaging (2011) 0.88
Preoperative CT evaluation of potential donors in living donor liver transplantation. Indian J Radiol Imaging (2014) 0.83
Newer CT applications and their alternatives: what is appropriate in children? Pediatr Radiol (2011) 0.83
Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT. PLoS One (2015) 0.82
Chemical shift imaging at 3 Tesla: effect of echo time on assessing bone marrow abnormalities. Skeletal Radiol (2014) 0.81
Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis. World J Gastroenterol (2014) 0.81
Evaluation of living liver donors using contrast enhanced multidetector CT - The radiologists impact on donor selection. BMC Med Imaging (2012) 0.80
Initial clinical application of modified Dixon with flexible echo times: hepatic and pancreatic fat assessments in comparison with (1)H MRS. MAGMA (2013) 0.80
Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease. Pediatr Radiol (2014) 0.80
Normal range of hepatic fat fraction on dual- and triple-echo fat quantification MR in children. PLoS One (2015) 0.79
Is MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice? PLoS One (2014) 0.79
Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls. Int J Endocrinol (2014) 0.78
Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride. Dig Dis Sci (2013) 0.78
In vivo and ex vivo measurements: noninvasive assessment of alcoholic fatty liver using 1H-MR spectroscopy. Diagn Interv Radiol (2015) 0.78
Diagnostic accuracy of dual-echo (in- and opposed-phase) T1-weighted gradient recalled echo for detection and grading of hepatic iron using quantitative and visual assessment. Eur Radiol (2014) 0.77
Hepatic fat during fasting and refeeding by MRI fat quantification. J Magn Reson Imaging (2014) 0.76
Heterogeneous living donor hepatic fat distribution on MRI chemical shift imaging. Ann Surg Treat Res (2015) 0.76
Chemical shift MR imaging methods for the quantification of transcatheter lipiodol delivery to the liver: preclinical feasibility studies in a rodent model. Radiology (2012) 0.75
Invited commentary. Radiographics (2009) 0.75
State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization. J Hepatocell Carcinoma (2015) 0.75
Xenon 133 ventilation studies as an alternative for detecting and quantifying fatty infiltration of the liver. Radiographics (2010) 0.75
Imaging evaluation in metabolic syndrome: beyond steatosis. Radiol Bras (2016) 0.75
Hepatic fat quantification magnetic resonance for monitoring treatment response in pediatric nonalcoholic steatohepatitis. World J Gastroenterol (2015) 0.75
Noninvasive methods to diagnose NAFLD. Saudi J Gastroenterol (2015) 0.75
Comparisons of parallel potential biomarkers of 1H-MRS-measured hepatic lipid content in patients with non-alcoholic fatty liver disease. Sci Rep (2016) 0.75
Clinical implication of ectopic liver lipid accumulation in renal cell carcinoma patients without visceral obesity. Sci Rep (2017) 0.75
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med (2010) 36.78
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med (2011) 16.94
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol (2009) 15.23
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med (2004) 9.80
ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol (2012) 9.76
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med (2003) 9.09
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers. Sci Transl Med (2012) 8.41
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature (2011) 8.03
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clin Cancer Res (2009) 7.35
Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn (2005) 6.00
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib. Cancer Discov (2012) 4.72
International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas (2011) 4.56
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J Clin Oncol (2009) 4.54
Biomarkers of response and resistance to antiangiogenic therapy. Nat Rev Clin Oncol (2009) 4.17
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet (2011) 3.92
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery (2012) 3.87
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol (2005) 3.83
Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology (2010) 3.60
mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature (2012) 3.51
Acquired resistance to crizotinib from a mutation in CD74-ROS1. N Engl J Med (2013) 3.42
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study. J Clin Oncol (2009) 3.39
Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models. Cancer Cell (2012) 3.39
Recent measures to improve radiology reporting: perspectives from primary care physicians. J Am Coll Radiol (2012) 3.32
Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol (2006) 3.28
Adult intestinal intussusception: CT appearances and identification of a causative lead point. Radiographics (2006) 3.22
Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology (2005) 3.01
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology (2007) 2.96
Comprehensive microscopy of the esophagus in human patients with optical frequency domain imaging. Gastrointest Endosc (2008) 2.94
Case records of the Massachusetts General Hospital. Case 15-2006. A 46-year-old woman with sudden onset of abdominal distention. N Engl J Med (2006) 2.92
Urine leaks and urinomas: diagnosis and imaging-guided intervention. Radiographics (2003) 2.73
ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer. Clin Cancer Res (2013) 2.65
Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res (2009) 2.62
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics (2009) 2.47
Acute epiploic appendagitis and its mimics. Radiographics (2005) 2.46
Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis. Arch Pathol Lab Med (2006) 2.46
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg (2008) 2.45
CT appearance of acute appendagitis. AJR Am J Roentgenol (2004) 2.39
Pancreatic cysts 3 cm or smaller: how aggressive should treatment be? Radiology (2006) 2.35
Radiation dose reduction at multidetector CT with adaptive statistical iterative reconstruction for evaluation of urolithiasis: how low can we go? Radiology (2012) 2.35
Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography. Gastrointest Endosc (2006) 2.31
Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlations. Arch Pathol Lab Med (2009) 2.30
Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg (2005) 2.27
Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology (2008) 2.27
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study. Lancet Oncol (2009) 2.23
Reducing abdominal CT radiation dose with adaptive statistical iterative reconstruction technique. Invest Radiol (2010) 2.23
HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol (2011) 2.10
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 27-2003. A 36-year-old man with recurrent epigastric pain and elevated amylase levels. N Engl J Med (2003) 2.09
Body CT scanning in young adults: examination indications, patient outcomes, and risk of radiation-induced cancer. Radiology (2013) 2.09
Dropped appendicolith: CT findings and implications for management. AJR Am J Roentgenol (2008) 2.03
Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics (2005) 2.03
Plectin-1 as a novel biomarker for pancreatic cancer. Clin Cancer Res (2010) 2.03
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer. Sci Transl Med (2013) 1.98
CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology (2002) 1.98
Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology (2010) 1.95
Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut (2011) 1.94
Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology (2005) 1.91
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol (2009) 1.90
Angiotensin II drives the production of tumor-promoting macrophages. Immunity (2013) 1.88
Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncology. Oncologist (2012) 1.88
Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. Radiology (2007) 1.87
Pheochromocytoma: an imaging chameleon. Radiographics (2004) 1.84
Autoimmune pancreatitis: more than just a pancreatic disease? A contemporary review of its pathology. Arch Pathol Lab Med (2005) 1.80
Image-guided biopsy in the esophagus through comprehensive optical frequency domain imaging and laser marking: a study in living swine. Gastrointest Endosc (2009) 1.79
Transgluteal approach for percutaneous drainage of deep pelvic abscesses: 154 cases. Radiology (2003) 1.78
FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Oncologist (2013) 1.76
Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology (2011) 1.73
Image-guided percutaneous splenic interventions. Radiographics (2012) 1.73
Uterine smooth-muscle tumors with unusual growth patterns: imaging with pathologic correlation. AJR Am J Roentgenol (2007) 1.72
EUS-guided injection of paclitaxel (OncoGel) provides therapeutic drug concentrations in the porcine pancreas (with video). Gastrointest Endosc (2006) 1.69
Volumetric optical frequency domain imaging of pulmonary pathology with precise correlation to histopathology. Chest (2013) 1.68
Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients. AJR Am J Roentgenol (2009) 1.68
Body perfusion CT: technique, clinical applications, and advances. Radiol Clin North Am (2009) 1.67
TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF-mutant melanoma. Sci Transl Med (2013) 1.67
Venous thromboembolism: indirect CT venography during CT pulmonary angiography--should the pelvis be imaged? Radiology (2008) 1.65
Determination of renal stone composition in phantom and patients using single-source dual-energy computed tomography. J Comput Assist Tomogr (2013) 1.64
Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol (2008) 1.62
Differential renal function estimation using computerized tomography based renal parenchymal volume measurement. J Urol (2010) 1.62
Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol (2006) 1.62
Vascular and biliary variants in the liver: implications for liver surgery. Radiographics (2008) 1.62
Risk factor analysis for the recurrence of resected solitary fibrous tumours of the pleura: a 33-year experience and proposal for a scoring system. Eur J Cardiothorac Surg (2012) 1.61
Concentration-dependent ablation of pancreatic tissue by EUS-guided ethanol injection. Gastrointest Endosc (2007) 1.61
Causes of renal forniceal rupture. BJU Int (2011) 1.60
Impact of obesity on medical imaging and image-guided intervention. AJR Am J Roentgenol (2007) 1.58
PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1. Proc Natl Acad Sci U S A (2013) 1.57
Case records of the Massachusetts General Hospital. Case 10-2012. A 16-year-old boy with epigastric pain and a mediastinal mass. N Engl J Med (2012) 1.54
Role of computed tomography perfusion in the evaluation of pancreatic necrosis and pancreatitis after endoscopic ultrasound-guided ablation of the pancreas in a porcine model. Pancreas (2009) 1.50
Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT--10-minute delayed imaging protocol revisited in a large patient cohort. Radiology (2010) 1.49